Press Release
Ortho Clinical Diagnostics Named Clinical Diagnostic Supplier of the Year by Cardinal Health
May 1, 2022
Innovations, Industry-Firsts and Best-In-Class Customer Service
Propelled Company to the Top
Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, has been recognized by Cardinal Health as the 2021 Clinical Diagnostic Supplier of the Year. Ortho was recognized out of 400 vendors for its strong commitment to patient care through operational excellence in logistics, testing and equipment supply.
Ortho has a strong presence across Cardinal Health’s laboratory business and is a trusted vendor to Cardinal Heath (NYSE: CAH). Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. Most recently, the companies worked together to ensure a stable supply of COVID-19 diagnostic tests and consumables laboratories across the world.
“Ortho is proud to collaborate with partners like Cardinal Health that put patients first to collectively create solutions that help ensure health care facilities have continued access to diagnostic solutions,” said Warren Stone, president, Americas, Ortho Clinical Diagnostics. “Like our distributor partners, Ortho is motivated to improve laboratory capabilities so they can provide the highest quality of care —Because Every Test Is a Life™.”
About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics (NASDAQ: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies.
More than 800,000 patients across the world are impacted by Ortho’s tests each day. Because Every Test is a Life™, Ortho provides hospitals, hospital networks, clinical laboratories, and blood banks around the globe with innovative IVD technologies to ensure that test results are fast, accurate and reliable. Ortho helps its customers enhance clinical outcomes, improve efficiency, overcome staffing challenges and reduce costs.
As a pioneering leader in IVD for more than over 80 years, Ortho launched the first product to determine Rh+ or Rh- blood type, developed the world’s first tests for the detection of antibodies against HIV and hepatitis C, introduced patented dry-slide technology, and was the first company to receive U.S. Food and Drug Administration (FDA) authorization for a high-volume antibody and antigen test for COVID-19.
The company is known industry-wide for Ortho Care™, its holistic customer support program which ensures technical, field and remote service and inventory support in more than 130 countries and territories.
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 40 countries and approximately 48,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.
Investor Contact:
IR@quidelortho.com
Media Contact:
media@quidelortho.com
